Protocol for Kleihauer-Betke Test After a Fall in Rh-Negative Pregnant Patients
A Kleihauer-Betke test should be performed for all Rh-negative pregnant women who experience a fall or abdominal trauma to quantify potential fetomaternal hemorrhage and determine the appropriate dose of Rh immune globulin needed to prevent alloimmunization. 1, 2
Rationale for Testing
- Fetal RhD antigens are well-developed by 6 weeks' gestation, creating potential for maternal sensitization even in early pregnancy 3
- Trauma, especially abdominal trauma, significantly increases the risk of fetomaternal hemorrhage (FMH) 1
- A positive Kleihauer-Betke test accurately predicts the risk of preterm labor after maternal trauma 1
Testing Protocol
Obtain maternal blood sample:
Perform Kleihauer-Betke test:
Interpret results:
- Positive test: Indicates fetomaternal hemorrhage has occurred
- Negative test: No evidence of significant fetomaternal hemorrhage
Rh Immune Globulin Dosing Protocol
Standard dosing (when FMH ≤15 mL of fetal red blood cells):
- Administer one full dose (300 mcg) of Rh immune globulin intramuscularly 2
Calculated dosing (when FMH >15 mL of fetal red blood cells):
Route of administration:
- Always administer intramuscularly, NEVER intravenously 2
Additional Monitoring
- All patients with a positive Kleihauer-Betke test should receive electronic fetal monitoring due to increased risk of preterm labor 1
- With a negative Kleihauer-Betke test, limited monitoring may be appropriate as the risk of preterm labor is significantly lower 1
Important Considerations
- The Kleihauer-Betke test may have false positives in mothers with hereditary elevation of fetal hemoglobin 4
- Flow cytometry may provide more accurate results but is not universally available 5
- Studies show FMH occurs in 52-60% of pregnancies, but most (87-92.5%) involve <10 mL of fetal blood 6
- In rare cases (1.3-2.7%), FMH may exceed 30 mL, requiring multiple doses of Rh immune globulin 6
Timing Considerations
- If the fall/trauma occurs at 13-18 weeks' gestation and Rh immune globulin is administered, another full dose should be given at 26-28 weeks 2
- If delivery occurs within 3 weeks after the last dose, the postpartum dose may be withheld unless there is significant FMH 2
This protocol ensures appropriate assessment and management of potential fetomaternal hemorrhage following trauma in Rh-negative pregnant women, helping prevent Rh alloimmunization and its associated complications.